"史帝富"普麗液

Država: Tajvan

Jezik: kitajščina

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Aktivna sestavina:

TAR B.P.;;CADE OIL BPC;;COAL TAR SOLUTION BP;;ARACHIS OIL BP EXTRACT OF COAL TAR BP

Dostopno od:

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438)

Koda artikla:

D05AA

Farmacevtska oblika:

外用液劑

Sestava:

TAR B.P. (8408001220) %(W/W); ARACHIS OIL BP EXTRACT OF COAL TAR BP (8424800600) %(W/W); COAL TAR SOLUTION BP (8432000182) %(W/W); CADE OIL BPC (9200005220) %(W/W)

Enote v paketu:

瓶裝

Razred:

製　劑

Tip zastaranja:

醫師藥師藥劑生指示藥品

Izdeluje:

STIEFEL LABORATORIES (PTE) LTD 103 GUL CIRCLE,SINGAPORE 629589 SG

Terapevtsko območje:

Tars

Terapevtske indikacije:

牛皮癬、濕疹、搔癢皮膚病

Povzetek izdelek:

註銷日期: 2016/05/30; 註銷理由: 許可證已逾有效期; 有效日期: 2014/01/27; 英文品名: POLYTAR EMOLLIENT

Status dovoljenje:

已註銷

Datum dovoljenje:

2009-06-12

Navodilo za uporabo

POLYTAR EMOLLIENT
TM
FORMULATIONS AND STRENGTH
POLYTAR EMOLLIENT
TM
each g contains: Polytar 0.25g (include: Juniper Tar 7.5%, Pine Tar
7.5%,
Coal Tar Solution 2.5%, Arachis Oil Extract of Crude Coal Tar 7.5%)
and excipients Liquid Paraffin
0.35g
EXCIPIENTS
Light liquid paraffin
Octyl phenoxypolyethoxyethanol
Sorbitan mono-oleate
Isopropyl palmitate
Polyethylene glycol 400 dilaurate
CLINICAL INFORMATION
INDICATIONS
Psoriasis
Eczema
Pruritic dermatoses
DOSAGE AND ADMINISTRATION
Shake before use. 2 to 4 capfuls of POLYTAR EMOLLIENT
TM
should be added to a bath containing 8 inches of water and
the patient instructed to soak for15- 20 minutes or applied directly
to the affected area and pat dry.
The treatment could combine with UV radiation or other therapy.
Contraindications
KNOWN HYPERSENSITIVITY TO COAL TAR, ARACHIS OIL (PEANUT OIL) OR TO ANY
OF THE EXCIPIENTS IN THE PREPARATION
(SEE WARNINGS AND PRECAUTIONS)
THE FOLLOWING CONDITIONS SHOULD NOT BE TREATED WITH POLYTAR EMOLLIENT
TM
:
INFECTED OPEN SKIN LESIONS
SORE OR ACUTE PUSTULAR PSORIASIS
Warnings and Precautions
FOR CUTANEOUS USE ONLY.
COAL TAR PREPARATIONS MAY CAUSE IRRITANCY, THEREFORE CONTACT WITH
SENSITIVE AREAS, SUCH AS BROKEN OR VERY
INFLAMED SKIN, SHOULD BE AVOIDED.
IF IRRITATION DEVELOPS, TREATMENT SHOULD BE DISCONTINUED.
AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS RINSE EYES THOROUGHLY
WITH WATER.
POLYTAR EMOLLIENT TM CAN STAIN SKIN AND CLOTHES. CONTACT WITH CLOTHES
SHOULD BE AVOIDED. SKIN STAINS WILL
WEAR OFF AFTER TREATMENT IS STOPPED.
IN RARE INSTANCES, TEMPORARY HAIR COLOUR CHANGES MAY OCCUR.
AS POLYTAR EMOLLIENT
TM MAY CAUSE INCREASED SENSITIVITY TO SUNLIGHT, EXPOSURE TO ARTIFICIAL
SOURCES OF UV
LIGHT, SUCH AS SUNLAMPS SHOULD BE AVOIDED UNLESS THE UV IS BEING USED
AS PART OF A TREATMENT REGIMEN.
WHEN EXPOSURE TO STRONG SUNLIGHT CANNOT BE AVOIDED, PATIENTS SHOULD BE
ADVISED TO USE A SUNSCREEN PRODUCT
AND WEAR PROTECTIVE CLOTHING. DUE TO THE POTENTIAL FOR
PHOTOSENSITIVITY, RESULTING IN GREATER RISK FOR SUNBURN,
POLYTAR EMOLLIENT
TM SHOULD BE USE